Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors.

Noriyasu Kato, Mitsuru Oka, Takayo Murase, Masahiro Yoshida, Masao Sakairi, Mirensha Yakufu, Satoko Yamashita, Yoshika Yasuda, Aya Yoshikawa, Yuji Hayashi, Masahiro Shirai, Yukie Mizuno, Mitsuaki Takeuchi, Mitsuhiro Makino, Motohiro Takeda, Takuji Kakigami
{"title":"Synthesis and pharmacological characterization of potent, selective, and orally bioavailable isoindoline class dipeptidyl peptidase IV inhibitors.","authors":"Noriyasu Kato,&nbsp;Mitsuru Oka,&nbsp;Takayo Murase,&nbsp;Masahiro Yoshida,&nbsp;Masao Sakairi,&nbsp;Mirensha Yakufu,&nbsp;Satoko Yamashita,&nbsp;Yoshika Yasuda,&nbsp;Aya Yoshikawa,&nbsp;Yuji Hayashi,&nbsp;Masahiro Shirai,&nbsp;Yukie Mizuno,&nbsp;Mitsuaki Takeuchi,&nbsp;Mitsuhiro Makino,&nbsp;Motohiro Takeda,&nbsp;Takuji Kakigami","doi":"10.1186/2191-2858-1-7","DOIUrl":null,"url":null,"abstract":"<p><p> Focused structure-activity relationships of isoindoline class DPP-IV inhibitors have led to the discovery of 4b as a highly selective, potent inhibitor of DPP-IV. In vivo studies in Wistar/ST rats showed that 4b was converted into the strongly active metabolite 4l in high yield, resulting in good in vivo efficacy for antihyperglycemic activity.</p>","PeriodicalId":19639,"journal":{"name":"Organic and Medicinal Chemistry Letters","volume":" ","pages":"7"},"PeriodicalIF":0.0000,"publicationDate":"2011-09-12","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://sci-hub-pdf.com/10.1186/2191-2858-1-7","citationCount":"20","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Organic and Medicinal Chemistry Letters","FirstCategoryId":"1085","ListUrlMain":"https://doi.org/10.1186/2191-2858-1-7","RegionNum":0,"RegionCategory":null,"ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"","JCRName":"","Score":null,"Total":0}
引用次数: 20

Abstract

Focused structure-activity relationships of isoindoline class DPP-IV inhibitors have led to the discovery of 4b as a highly selective, potent inhibitor of DPP-IV. In vivo studies in Wistar/ST rats showed that 4b was converted into the strongly active metabolite 4l in high yield, resulting in good in vivo efficacy for antihyperglycemic activity.

Abstract Image

Abstract Image

强效、选择性和口服生物可利用的异吲哚啉类二肽基肽酶IV抑制剂的合成和药理学表征。
关注异吲哚啉类DPP-IV抑制剂的结构-活性关系导致发现4b是DPP-IV的高选择性有效抑制剂。Wistar/ST大鼠体内实验表明,4b能高产地转化为活性强的代谢产物4l,具有良好的体内降糖活性。
本文章由计算机程序翻译,如有差异,请以英文原文为准。
求助全文
约1分钟内获得全文 求助全文
来源期刊
自引率
0.00%
发文量
0
×
引用
GB/T 7714-2015
复制
MLA
复制
APA
复制
导出至
BibTeX EndNote RefMan NoteFirst NoteExpress
×
提示
您的信息不完整,为了账户安全,请先补充。
现在去补充
×
提示
您因"违规操作"
具体请查看互助需知
我知道了
×
提示
确定
请完成安全验证×
copy
已复制链接
快去分享给好友吧!
我知道了
右上角分享
点击右上角分享
0
联系我们:info@booksci.cn Book学术提供免费学术资源搜索服务,方便国内外学者检索中英文文献。致力于提供最便捷和优质的服务体验。 Copyright © 2023 布克学术 All rights reserved.
京ICP备2023020795号-1
ghs 京公网安备 11010802042870号
Book学术文献互助
Book学术文献互助群
群 号:481959085
Book学术官方微信